Publicado jul 1, 2021



PLUMX
Almetrics
 
Dimensions
 

Google Scholar
 
Search GoogleScholar


Melisa Bermúdez Bermúdez

Karen Margarita Cuadro Montero

Erika Alexandra Parra Sanabria

Andrés Rueda Jiménez

Claudia Patricia Peña Vega

##plugins.themes.bootstrap3.article.details##

Resumen

Objetivo: Describir y analizar los reportes de casos y estudios publicados, en los que se presente una posible relación entre la COVID-19 y lesiones mucocutáneas en cavidad oral y cara. Metodología: Se realizó una revisión en las bases de datos de PubMed, Google Académico, ProQuest y Medline Complete, se seleccionaron 56 artículos que reportan manifestaciones mucocutáneas en cavidad oral y cara asociadas a la COVID-19. Resultados: Se encontraron 91 casos reportados con manifestaciones mucocutáneas en cavidad oral y cara, asociadas a la COVID-19. El 18% de los pacientes presentó lesiones tanto a nivel facial como oral. Las mejillas fueron las zonas más afectadas representando un 16% y de las lesiones orales el sitio más afectado fue el paladar con el 26%. Conclusión: De acuerdo con los hallazgos encontrados, la presencia de manifestaciones mucocutáneas en cara y cavidad oral están asociadas a la infección por SARS-CoV 2. Es de esperarse que los tejidos con mayor expresión de la ECA2 y TMPRSS2, sean más susceptibles a la infección por el SARS-CoV 2 y por consiguiente presenten algún tipo de lesión. Dentro de los tejidos orales con mayor expresión de dichas moléculas se describió la lengua, lo que favorecería mayor prevalencia de lesiones.

Keywords

COVID-19, facial, mucous membrane, oral manifestationsCOVID-19, facial, mucosa, manifestaciones orales

References
1. Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020;14(2):185–92.
2. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020 Jun 1;215:1–7.
3. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA [Internet]. 2020 Jul 10; Available from: http://www.ncbi.nlm.nih.gov/pubmed/32648899
4. Zhang H, Kang Z, Gong H, Xu D, Wang J, Li Z, et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv [Internet]. 2020 Jan 1; Available from: http://biorxiv.org/content/early/2020/01/31/2020.01.30.927806.abstract
5. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020 Apr 1;10(2):102–8.
6. Cao W, Li T. COVID-19: towards understanding of pathogenesis. Cell Res. 2020 May 1;30(5):367–9.
7. Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun [Internet]. 2020;11(1):1–12. Available from: http://dx.doi.org/10.1038/s41467-020-15562-9
8. Sakaguchi W, Kubota N, Shimizu T, Saruta J, Fuchida S, Kawata A, et al. Existence of SARS-CoV-2 entry molecules in the oral cavity. Int J Mol Sci. 2020;21(17):1–16.
9. Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci [Internet]. 2020;12(8). Available from: http://dx.doi.org/10.1038/s41368-020-0074-x
10. Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández Nieto D, Rodríguez-Villa Lario A, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183:71–7.
11. Ciccarese G, Drago F, Boatti M, Porro A, Muzic SI, Parodi A. Oral erosions and petechiae during SARS-CoV-2 infection. J Med Virol [Internet]. 2020; Available from: https://doi.org/10.1002/jmv.26221
12. Sinadinos A, Shelswell J. Oral ulceration and blistering in patients with COVID-19. Evid Based Dent. 2020;21(2):49.
13. Vinayachandran D, Balasubramanian S. Is Gustatory Impairment the First Report of an Oral Manifestation in COVID-19? Oral Dis. 2020;1–5.
14. Biadsee AA, Biadsee AA, Kassem F, Dagan O, Masarwa S, Ormianer Z. Olfactory and Oral Manifestations of COVID-19: Sex-Related Symptoms—A Potential Pathway to Early Diagnosis. Otolaryngol - Head Neck Surg (United States). 2020;163(4):722–8.
15. Patel J, Woolley J. Necrotizing periodontal disease: Oral manifestation of COVID‐19. Oral Dis. 2020;0–2.
16. Ansari R, Gheitani M, Heidari FF, Heidari FF. Oral cavity lesions as a manifestation of the novel virus (COVID‐19): a letter‐to‐editor. Oral Dis. 2020 Jun 8;
17. Al‐Khatib A. Oral manifestations in COVID‐19 patients. Oral Dis. 2020;1–2.
18. das Chagas e Silva de Carvalho LF, Kitakawa D, Cabral LAG. Oral lesions of herpes zoster in COVID‐19 patients or truly associated to the disease? Oral Dis. 2020 Jun 10;1–2.
19. Marzano A V., Cassano N, Genovese G, Moltrasio C, Vena GA. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue. Br J Dermatol. 2020;183(3):431–42.
20. Perrillat A, Foletti JM, Lacagne AS, Guyot L, Graillon N. Facial pressure ulcers in COVID-19 patients undergoing prone positioning: How to prevent an underestimated epidemic? J Stomatol oral Maxillofac Surg. 2020 Jun 18;1–3.
21. Karagounis TK, Shaw KS, Caplan A, Lo Sicco K, Femia AN. Acrofacial purpura and necrotic ulcerations in COVID-19: a case series from New York City. Int J Dermatol. 2020;59(11):1419–22.
22. Brandão TB, Gueiros LA, Melo TS, Prado-Ribeiro AC, Nesrallah ACFA, Prado GVB, et al. Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ? Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;(January).
23. Fitzpatrick SG, Cohen DM, Clark AN. Ulcerated Lesions of the Oral Mucosa: Clinical and Histologic Review. Head Neck Pathol [Internet]. 2019;13(1):91–102. Available from: http://dx.doi.org/10.1007/s12105-018-0981-8
24. Chérif MY, de Filette JMK, André S, Kamgang P, Richert B, Clevenbergh P. Coronavirus disease 2019–related Kawasaki-like disease in an adult: A case report. JAAD Case Reports. 2020;6(8):780–2.
25. Kämmerer T, Walch J, Flaig M, French LE. COVID-19-associated herpetic gingivostomatitis. Clin Exp Dermatol. 2021;46(1):174–6.
26. Bezerra TM, Feitosa SG, Carneiro DTO, Costa FWG, Pires FR, Pereira KMA. Oral lesions in COVID-19 infection: Is long-term follow-up important in the affected patients? Oral Dis. 2020;(October):1–2.
27. Carreras Presas MC, Amaro Sánchez J, López Sánchez AF, Jané Salas E, Somacarrera Pérez ML. Oral vesiculobullous lesions associated with SARS-CoV-2 infection. Oral Dis. 2020;
28. Chaux-Bodard A-G, Deneuve S, Desoutter A. Oral manifestation of Covid-19 as an inaugural symptom? J Oral Med Oral Surg. 2020;26(18):1.
29. Sakaida T, Tanimoto I, Matsubara A, Nakamura M, Morita A. Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19? Journal of Dermatological Science. Elsevier Ireland Ltd; 2020.
30. Santos JA dos, Normando AGC, Silva RLC da, Paula RM De, Cembranel AC, Santos-Silva AR, et al. Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations? Int J Infect Dis. 2020 Jun;97.
31. Soares C, Carvalho R, Carvalho K, Carvalho M, Almeida O. Letter to Editor: Oral lesions in a patient with Covid-19. Med Oral Patol Oral y Cir Bucal. 2020;25(4):563–4.
32. Demirbaş A, Elmas ÖF, Atasoy M, Türsen Ü, Lotti T. A case of erythema multiforme major in a patient with COVID 19: The role of corticosteroid treatment. Dermatol Ther. 2020;
33. Abou Assalie N, Durcan R, Durcan L, Petri MA. Hydroxychloroquine-induced erythema multiforme. J Clin Rheumatol. 2017;23(2):127–8.
34. Zuo W, Wen L, Li J, Mei D, Fu Q, Zhang B. Oseltamivir induced Stevens – Johnson syndrome/ toxic epidermal necrolysis — case report. :1–4.
35. Dominguez-Santas M, Diaz-Guimaraens B, Fernandez-Nieto D, Jimenez-Cauhe J, Ortega-Quijano D, Suarez-Valle A. Minor aphthae associated with SARS-CoV-2 infection. Int J Dermatol. 2020;59(8):1022–3.
36. Gottlieb M, Long B. Dermatologic manifestations and complications of COVID-19. Am J Emerg Med [Internet]. 2020;38(9):1715–21. Available from: https://doi.org/10.1016/j.ajem.2020.06.011
37. Díaz Rodríguez M, Jimenez Romera A, Villarroel M. Oral manifestations associated with COVID-19. Oral Dis. 2020;
38. Taşkın B, Vural S, Altuğ E, Demirkesen C, Kocatürk E, Çelebi, et al. Coronavirus 19 presenting with atypical Sweet’s syndrome. J Eur Acad Dermatology Venereol. 2020;34(10):e534–5.
39. Putra BE, Adiarto S, Dewayanti SR, Juzar DA. Viral exanthem with “Spins and needles sensation” on extremities of a COVID-19 patient: A self-reported case from an Indonesian medical frontliner. Int J Infect Dis [Internet]. 2020 Jul 1;96:355–8. Available from: https://doi.org/10.1016/j.ijid.2020.05.020
40. Corchuelo J, Chavier F. Oral manifestations in a patient with a history of asymptomatic COVID-19: Case report. Int J Infect Dis. 2020;100:154–7.
41. Jimenez-Cauhe J, Ortega-Quijano D, de Perosanz-Lobo D, Burgos-Blasco P, Vañó-Galván S, Fernandez-Guarino M, et al. Enanthem in Patients With COVID-19 and Skin Rash. JAMA dermatology [Internet]. 2020 Jul 15; Available from: http://www.ncbi.nlm.nih.gov/pubmed/32667631
42. Cruz Tapia RO, Peraza Labrador AJ, Guimaraes DM, Matos Valdez LH. Oral mucosal lesions in patients with SARS-CoV-2 infection. Report of four cases. Are they a true sign of COVID-19 disease? Spec Care Dent. 2020;40(6):555–60.
43. Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020;220(January):1–13.
44. Cebeci Kahraman F, Çaşkurlu H. Mucosal involvement in a COVID-19-positive patient: A case report. Vol. 33, Dermatologic Therapy. 2020.
45. Navaeifar MR, Ghazaghi MP, Shahbaznejad L, Rouhanizadeh H, Abutalebi M, Varandi MR, et al. Fever with rash is one of the first presentations of COVID-19 in children: A case report. Int Med Case Rep J. 2020;13:335–40.
46. Chiu JS, Lahoud-Rahme M, Schaffer D, Cohen A, Samuels-Kalow M. Kawasaki Disease Features and Myocarditis in a Patient with COVID-19. Pediatr Cardiol [Internet]. 2020;41(7):1526–8. Available from: https://doi.org/10.1007/s00246-020-02393-0
47. Malih N, Hajinasrollah G, Zare M, Taheri M. Unexpected Presentation of COVID-19 in a 38-Year-Old Male Patient: A Case Report. Case Rep Dermatol. 2020;12(2):124–31.
48. Tomo S, Miyahara GI, Simonato LE. Oral mucositis in a SARS-CoV-2-infected patient: Secondary or truly associated condition? Oral Dis. 2020;(July):1–5.
49. Olisova OY, Anpilogova EM, Shnakhova LM. Cutaneous manifestations in COVID-19: a skin rash in a child. Dermatol Ther. 2020;(May):1–2.
50. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020 Jul;5(7):831–40.
51. Cebeci Kahraman F, Özen T, Elibol T. Lip necrosis in a patient with paroxysmal nocturnal hemoglobinuria: Can it be triggered by COVID-19? J Cosmet Dermatol. 2020;
52. Singh C, Tay J, Shoqirat N. Skin and mucosal damage in patients diagnosed with CoviD-19 a case report. J Wound, Ostomy Cont Nurs. 2020;47(5):435–8.
53. Mazzotta F, Troccoli T, Caselli D, Bonifazi E. Acral rash in a child with COVID-19. Eur J Pediatr Dermatology. 2020;30(2):79–82.
54. Labé P, Ly A, Sin C, Nasser M, Chapelon-Fromont E, Ben Saïd P, et al. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children. J Eur Acad Dermatology Venereol. 2020;34(10):e539–41.
55. Farouk S, Sadek A. Cutaneous manifestations of COVID-19: A case report and a new finding from Egypt. Dermatol Ther. 2020;
56. Manzalawi R, Alhmamey K, Abdelrasoul M. Gingival bleeding associated with COVID-19 infection. Clin Case Reports. 2021;9(1):294–7.
57. Scully C, Samaranayake LP. Emerging and changing viral diseases in the new millennium. Oral Dis. 2016 Apr 1;22(3):171–9.
58. Kitakawa D, Oliveira FE, Neves De Castro P, Carvalho LFCS. Short report - Herpes simplex lesion in the lip semimucosa in a COVID-19 patient. Eur Rev Med Pharmacol Sci. 2020;24(17):9151–3.
59. Aghazadeh N, Homayouni M, Sartori-Valinotti JC. Oral vesicles and acral erythema: report of a cutaneous manifestation of COVID-19. Int J Dermatol. 2020;59(9):1153–4.
60. de Freitas Ferreira ACA, Romão TT, SIlva Macedo Y, Pupe C, Nascimento OJM. COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy. Eur J Neurol. 2020;
61. Farabi B, Atak MF. Isolated maculopapular eruption localized to head and neck: A cutaneous sign of COVID ‐19 infection . Dermatologic Therapy. 2020.
62. Riad A, Gad A, Hockova B, Klugar M. Oral candidiasis in non-severe COVID-19 patients: call for antibiotic stewardship. Oral Surg. 2020;1–2.
63. Salehi M, Ahmadikia K, Mahmoudi S, Kalantari S, Jamalimoghadamsiahkali S, Izadi A, et al. Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: Species identification and antifungal susceptibility pattern. Mycoses. 2020;63(8):771–8.
64. Zegarelli DJ. Fungal infections of the oral cavity. Otolaryngol Clin North Am. 1993 Dec;26(6):1069–89.
65. Pahl C, Yarrow S, Steventon N, Saeed NR, Dyar O. Angina bullosa haemorrhagica presenting as acute upper airway obstruction. BJA Br J Anaesth [Internet]. 2004 Feb 1;92(2):283–6. Available from: https://doi.org/10.1093/bja/aeh029
66. Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Bradley Segal J, et al. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. Hosp Pediatr. 2020;10(6).
67. Jones I, Bell LCK, Manson JJ, Last A. An adult presentation consistent with PIMS-TS. Lancet Rheumatol [Internet]. 2020 Jul; Available from: https://linkinghub.elsevier.com/retrieve/pii/S2665991320302344
68. Estébanez A, Pérez-Santiago L, Silva Es, Guillen-Climent S, García- Vázquez A, Ramón MD, et al. Cutaneous manifestations in COVID-19: a new contribution. J Eur Acad Dermatology Venereol. 2020;34(6):e250–1.
69. Morey-Olivé M, Espiau M, Mercadal-Hally M, Lera-Carballo E, García-Patos V. Cutaneous manifestations in the current pandemic of coronavirus infection disease (COVID 2019). An Pediatría (English Ed. 2020;92(6):374–5.
70. Fernandez Nieto D, Ortega Quijano D, Segurado Miravalles G, Pindado Ortega C, Prieto Barrios M, Jimenez Cauhe J, et al. Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies. J Eur Acad Dermatology Venereol. 2020;34(6):e252–4.
71. Henry D, Ackerman M, Sancelme E, Finon A, Esteve E. Urticarial eruption in COVID-19 infection. J Eur Acad Dermatology Venereol. 2020;34(6):e244–5.
72. Hedou M, Carsuzaa F, Chary E, Hainaut E, Cazenave-Roblot F, Masson Regnault M. Comment on ‘Cutaneous manifestations in COVID-19: a first perspective’ by Recalcati S. J Eur Acad Dermatology Venereol. 2020;34(7):e299–300.
73. van Damme C, Berlingin E, Saussez S, Accaputo O. Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection. J Eur Acad Dermatology Venereol. 2020;34(7):e300–1.
74. Lu S, Lin J, Zhang Z, Xiao L, Jiang Z, Chen J, et al. Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients. J Med Virol. 2020;(March):1–4.
75. Rivera-Oyola R, Koschitzky M, Printy R, Liu S, Stanger R, Golant AK, et al. Dermatologic findings in 2 patients with COVID-19. JAAD Case Reports [Internet]. 2020;6(6):537–9. Available from: https://doi.org/10.1016/j.jdcr.2020.04.027
76. Sanchez A, Sohier P, Benghanem S, L’Honneur A-S, Rozenberg F, Dupin N, et al. Digitate Papulosquamous Eruption Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. JAMA Dermatology [Internet]. 2020 Jul 1;156(7):819–20. Available from: https://doi.org/10.1001/jamadermatol.2020.1704
77. Amatore F, Macagno N, Mailhe M, Demarez B, Gaudy-Marqueste C, Grob JJ, et al. SARS-CoV-2 infection presenting as a febrile rash. J Eur Acad Dermatology Venereol. 2020;34(7):e304–6.
78. Gisondi P, Piaserico S, Conti A, Naldi L. Dermatologists and SARS-CoV-2: the impact of the pandemic on daily practice. J Eur Acad Dermatology Venereol. 2020;34(6):1196–201.
79. Pangti Rashi GS. Recognizable vascular skin manifestations of SARS CoV-2 infection are uncommon in patients with skin-of-color. 2020.
80. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatology Venereol. 2020;34(5):e212–3.
81. Kang JH. Febrile illness with skin rashes. Infect Chemother. 2015;47(3):155–66.
82. Ahouach B, Harent S, Ullmer A, Martres P, Bégon E, Blum L, et al. Cutaneous lesions in a patient with COVID-19: are they related? Br J Dermatol. 2020;183(2):e31.
83. Mahé A, Birckel E, Merklen C, Lefèbvre P, Hannedouche C, Jost M, et al. Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not ‘varicella-like.’ J Eur Acad Dermatology Venereol. 2020;34(10):e559–61.
84. Hoenig LJ, Pereira FA. Eruption as a clinical manifestation of COVID-19: photographs of a patient. Clin Dermatol. 2020;
85. Jimenez-Cauhe J, Ortega-Quijano D, Carretero-Barrio I, Suarez-Valle A, Saceda-Corralo D, Moreno-Garcia del Real C, et al. Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings. Clin Exp Dermatol. 2020;45(7):892–5.
86. Tatu AL, Nadasdy T, Bujoreanu FC. Familial clustering of COVID-19 skin manifestations. Dermatol Ther. 2020;
87. Rossi E, Lasagni C, Trakatelli M, Wertzberger Rowan S, Magnoni C. Acute maculopapular eruption in Covid-19 patient: A case report. Dermatol Ther. 2020;(June):9–11.
88. Paolino G, Canti V, Mercuri SR, Rovere Querini P, Candiani M, Pasi F. Diffuse cutaneous manifestation in a new mother with COVID-19 (SARS-Cov-2). Int J Dermatol. 2020;59(7):874–5.
89. Robustelli Test E, Vezzoli P, Carugno A, Raponi F, Gianatti A, Rongioletti F, et al. Acute generalized exanthematous pustulosis with erythema multiforme-like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID-19). J Eur Acad Dermatology Venereol. 2020;34(9):e457–9.
90. Rosell-Díaz AM, Mateos-Mayo A, Nieto-Benito LM, Balaguer-Franch I, Hernández de la Torre-Ruiz E, Lainez-Nuez A, et al. Exanthema and eosinophilia in COVID-19 patients: has viral infection a role in drug induced exanthemas? J Eur Acad Dermatology Venereol. 2020;34(10):e561–3.
91. Danarti R, Budiarso A, Rini DLU, Soebono H. Follicular eruption as a cutaneous manifestation in COVID-19. BMJ Case Rep. 2020;13(10):e238182.
92. Tamai M, Maekawa A, Goto N, Ge L, Nishida T, Iwahashi H, et al. Three cases of COVID-19 patients presenting with erythema. J Dermatol. 2020;47(10):1175–8.
93. Sadr PZ, Pishbin E, Khodashahi R. A young woman with a full‐body rash. J Am Coll Emerg Physicians Open. 2020;1(5):1145–6.
94. Lagziel T, Quiroga L, Ramos M, Hultman CS, Asif M. Two False Negative Test Results in a Symptomatic Patient with a Confirmed Case of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN). Cureus. 2020;2(5).
95. Torres-Navarro I, Abril-Pérez C, Roca-Ginés J, Sánchez-Arráez J, Botella-Estrada R. A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue. J Eur Acad Dermatology Venereol. 2020;34(10):e537–9.
96. Bursal Duramaz B, Yozgat CY, Yozgat Y, Turel O. Appearance of skin rash in pediatric patients with COVID-19: Three case presentations. Dermatol Ther. 2020;33(4):2–3.
97. Kaya G, Kaya A, Saurat J-H. Clinical and histopathological features and potential pathological mechanisms of skin lesions in COVID-19: Review of the literature. Dermatopathology. 2020;7(1):3–16.
Cómo citar
Bermúdez Bermúdez, M., Cuadro Montero, K. M., Parra Sanabria, E. A., Rueda Jiménez, A. ., & Peña Vega, C. P. (2021). Manifestaciones en la cavidad bucal y en la cara asociadas a la COVID-19. Universitas Medica, 62(3). https://doi.org/10.11144/Javeriana.umed62-3.mcbc
Sección
Artículos de revisión